Ameritas Investment Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,405
| Closed | -$740K | – | 784 |
|
|
2021
Q2 | $740K | Sell |
2,405
-1,684
| -41% | -$518K | 0.04% | 342 |
|
|
2021
Q1 | $625K | Buy |
4,089
+1,684
| +70% | +$258K | 0.05% | 299 |
|
|
2020
Q4 | $376K | Buy |
+2,405
| New | +$376K | 0.07% | 266 |
|
|
2020
Q2 | – | Sell |
-1,831
| Closed | -$164K | – | 1779 |
|
|
2020
Q1 | $164K | Buy |
1,831
+1,611
| +732% | +$144K | 0.03% | 386 |
|
|
2019
Q4 | $24K | Sell |
220
-1,421
| -87% | -$155K | 0.01% | 671 |
|
|
2019
Q3 | $179K | Buy |
+1,641
| New | +$179K | 0.04% | 345 |
|
|
2019
Q2 | – | Sell |
-1,611
| Closed | -$218K | – | 947 |
|
|
2019
Q1 | $218K | Buy |
1,611
+261
| +19% | +$35.3K | 0.04% | 288 |
|
|
2018
Q4 | $131K | Buy |
+1,350
| New | +$131K | 0.03% | 366 |
|